Medplus Health Services Allots 82,419 Equity Shares Under ESOP 2021 on 20 May 2026
Medplus Health Services allotted 82,419 equity shares under ESOP 2021 on May 20, 2026. The face value is ₹2 each. Consequently, the paid-up share capital increased from ₹24,01,09,284 to ₹24,02,74,122. Shares were issued to eligible employees. Exercise prices were ₹628, ₹541.98, and ₹232 per share for different tranches.
The allotment of shares under ESOP is a routine event and is unlikely to have a significant impact on the company's stock price or operations.
The announcement is a routine update regarding the allotment of shares under the ESOP, with no indication of positive or negative sentiment.
Medplus Health Services Limited has announced the allotment of 82,419 equity shares with a face value of ₹2 each, fully paid up, under its Employee Stock Option Plan 2021 (ESOP 2021). The allotment was approved by the Board of Directors at their meeting held on May 20, 2026, based on the recommendation of the Nomination and Remuneration Committee. These shares were issued to eligible employees of the Company and its Group Companies upon the exercise of stock options.
Consequent to this allotment, the paid-up share capital of the company has increased from 12,00,54,642 equity shares of ₹2 each, aggregating to ₹24,01,09,284, to 12,01,37,061 equity shares of ₹2 each, aggregating to ₹24,02,74,122. The company has filed the necessary disclosures under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 with the stock exchanges. These details are available on the company's website and the websites of BSE Limited and National Stock Exchange of India Limited.
The exercise price per share was: i) 2,938 equity shares exercised at ₹628 per share, ii) 33,210 equity shares exercised at ₹541.98 per share, and iii) 46,271 equity shares exercised at ₹232 per share.
What to do with a filing like this
Medplus Health Services Limited filed this with the NSE as a statutory disclosure, categorised under esg reports. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Medplus Health Services Limited. Read the original for the full detail.